CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia.

Authors :: Palmieri R
Buccisano F
Arena V
Irno Consalvo MA
Piciocchi A
Maurillo L
DelPrincipe MI
Di Veroli A
Paterno G
Conti C
Fraboni D
Voso MT
Arcese W
Venditti A
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2022 Apr; Vol. 63 (4), pp. 996-1000. Date of Electronic Publication: 2021 Nov 21.
Publication Year :: 2022

Subjects :: ADP-ribosyl Cyclase 1
Adult
Antigens, CD34
Flow Cytometry
Humans
Neoplastic Stem Cells
Prognosis
Stem Cells
Leukemia, Myeloid, Acute diagnosis

Full Text Access

Tools